109586-71-2

Upstream product

• 109586-65-4 Methyl-(Z)-6-<(2-endo,3-exo/endo)-3-<<2-(2-chlorphenyl)ethyl>carbamoyl>bicyclo<2.2.1>hept-5-en-2-yl>-5-hexenoat 
• 18970-81-5 (2-chlorophenyl)ethanamine hydrochloride 
• 109586-68-7 Methyl-6-<(2-exo,3-endo)-3-<(2-phenylethyl)carbamoyl>bicyclo<2.2.1>hept-2-yl>hexanoat 
• 109586-65-4 Methyl-(Z)-6-<(2-exo,3-exo/endo)-3-<<2-(2-chlorphenyl)ethyl>carbamoyl>bicyclo<2.2.1>hept-5-en-2-yl>-5-hexenoat 
• 109586-68-7 Methyl-6-<(2-exo,3-exo)-3-<(2-phenylethyl)carbamoyl>bicyclo<2.2.1>hept-2-yl>hexanoat 
• 100557-88-8 Methyl-(Z)-6-<(2-exo,3-exo/endo)-3-carboxybicyclo<2.2.1>hept-5-en-2-yl>5-hexenoat 
• 109586-74-5 Methyl-(Z)-6-<(2-exo,3-exo/endo)-3-formylbicyclo<2.2.1>hept-5-en-2-yl>5-hexenoat 
• 100557-88-8 Methyl-(Z)-6-<(2-endo,3-exo/endo)-3-carboxybicyclo<2.2.1>hept-5-en-2-yl>-5-hexenoat 

Relevant academic research and scientific papers

6-(3-Carbamoylbicyclohept-2-yl)hexanoic Acids, a New Class of TxA2 Antagonists

The synthesis of prostanoids 20-27, 40a, b, and 45a, b starting from the educts 1a, b, and 31 is described.Configurational changes concerning to the positions 2 and 3 of the bicyclic system were proofed by 13C-NMR spectroscopy and were also used for the preparation of the four exo/endo derivatives. 25 and 26 are potent TxA2 antagonists.